SCHEMBL5606465

SCHEMBL5606465

[CH2]Cn1c(=O)[nH]c2ccccc2c1=O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.70
ALDH1A1 P00352 4/20 0.68
HPGD P15428 3/20 0.68
KDM4E B2RXH2 3/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.57
HSD17B10 Q99714 1/20 0.57
MPO P05164 2/20 0.56
ADORA3 P0DMS8 1/20 0.56
ADORA2A P29274 1/20 0.56
ADORA2B P29275 1/20 0.56
ADORA1 P30542 1/20 0.56
CA12 O43570 1/20 0.56
RNASEH1 O60930 1/20 0.56
ERCC1 P07992 1/20 0.56
ERCC5 P28715 1/20 0.56
FEN1 P39748 1/20 0.56
CA9 Q16790 1/20 0.56
ERCC4 Q92889 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9523849 0.82 CYP1A2 (1.00) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL1260406 0.81 CYP1A2 (0.64) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL30877025 0.81 HPGD (1.00) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL6982894 0.81 HPGD (1.00) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL5878601 0.79 ALDH1A1 (0.82) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL30089550 0.79 ALDH1A1 (0.68) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL8074180 0.79 ALDH1A1 (0.68) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL4199990 0.79 ALDH1A1 (0.69) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL1662185 0.79 ALDH1A1 (0.68) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2
SCHEMBL30581253 0.79 ALDH1A1 (0.69) CYP1A2ALDH1A1HPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070253896-A1 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070253896-A1 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors HSP90B1, HSP90AB2P, HSP90AB1 CYP1A2 4229/4885ALDH1A1 2635/4885HPGD 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.